15.97
price up icon0.13%   0.02
after-market アフターアワーズ: 15.94 -0.03 -0.19%
loading
前日終値:
$15.95
開ける:
$15.93
24時間の取引高:
441.00K
Relative Volume:
0.98
時価総額:
$461.05M
収益:
$219.79M
当期純損益:
$-57.47M
株価収益率:
-7.4279
EPS:
-2.15
ネットキャッシュフロー:
$-19.25M
1週間 パフォーマンス:
-0.81%
1か月 パフォーマンス:
-19.55%
6か月 パフォーマンス:
-47.26%
1年 パフォーマンス:
-34.04%
1日の値動き範囲:
Value
$15.62
$16.06
1週間の範囲:
Value
$15.45
$16.43
52週間の値動き範囲:
Value
$15.45
$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name
名前
Castle Biosciences Inc
Name
セクター
Healthcare (1170)
Name
電話
866-788-9007
Name
住所
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Name
職員
784
Name
Twitter
@castlebio
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
CSTL's Discussions on Twitter

CSTL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
CSTL
Castle Biosciences Inc
15.97 464.84M 219.79M -57.47M -19.25M -2.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
402.82 148.60B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.90 132.07B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
513.36 40.34B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.92 30.82B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
140.33 23.70B 15.50B 1.33B 2.16B 7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-14 開始されました Guggenheim Buy
2023-01-05 開始されました Scotiabank Sector Outperform
2022-01-07 開始されました Stephens Overweight
2021-04-30 開始されました Lake Street Buy
2020-11-10 開始されました KeyBanc Capital Markets Overweight
2019-12-27 繰り返されました Canaccord Genuity Buy
2019-08-19 開始されました BTIG Research Buy
2019-08-19 開始されました Canaccord Genuity Buy
2019-08-19 開始されました Robert W. Baird Outperform
2019-08-19 開始されました SVB Leerink Outperform
すべてを表示

Castle Biosciences Inc (CSTL) 最新ニュース

pulisher
May 30, 2025

Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025 - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

Castle Biosciences Presents Innovative Research on Melanoma Risk Stratification at ASCO 2025 - Nasdaq

May 29, 2025
pulisher
May 29, 2025

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's - GlobeNewswire

May 29, 2025
pulisher
May 27, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 27, 2025
pulisher
May 27, 2025

Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 27, 2025

Nuveen Asset Management LLC Has $12.41 Million Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 24, 2025

Deutsche Bank AG Buys 7,495 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 24, 2025

Bank of America Corp DE Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote By Investing.com - Investing.com India

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences Holds Annual Stockholders Meeting - TipRanks

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote - Investing.com

May 23, 2025
pulisher
May 23, 2025

Some Confidence Is Lacking In Castle Biosciences, Inc. (NASDAQ:CSTL) As Shares Slide 28% - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences stock hits 52-week low at $15.66 - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences stock hits 52-week low at $15.66 By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Scotiabank Issues Pessimistic Forecast for Castle Biosciences (NASDAQ:CSTL) Stock Price - Defense World

May 23, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Price Target Revised by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healt - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences Executive Team Reveals Strategic Updates at Jefferies Healthcare Conference - Stock Titan

May 21, 2025
pulisher
May 21, 2025

90,563 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Purchased by D. E. Shaw & Co. Inc. - Defense World

May 21, 2025
pulisher
May 21, 2025

Ameriprise Financial Inc. Has $8.42 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 21, 2025
pulisher
May 19, 2025

Northern Trust Corp Boosts Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Jane Street Group LLC Reduces Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025
pulisher
May 14, 2025

Voya Investment Management LLC Sells 668 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 14, 2025
pulisher
May 13, 2025

Price T Rowe Associates Inc. MD Purchases 1,837 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 13, 2025
pulisher
May 10, 2025

Castle Biosciences confirms UM test’s efficacy - Investing.com

May 10, 2025
pulisher
May 10, 2025

Castle Biosciences confirms UM test’s efficacy By Investing.com - Investing.com India

May 10, 2025
pulisher
May 10, 2025

Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Ri - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Castle Biosciences to buy Previse - MSN

May 09, 2025
pulisher
May 09, 2025

Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Risk Prediction | CSTL Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Castle Biosciences Reports Independent Validation of DecisionDx-UM Test with PRAME Gene Expression Data at ARVO 2025 - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Real-World Study Confirms Long-Term Performance of - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Texas public company to acquire Baltimore cancer diagnostic firm - The Business Journals

May 09, 2025
pulisher
May 09, 2025

Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives - MSN

May 09, 2025
pulisher
May 08, 2025

Canaccord Genuity Group Has Lowered Expectations for Castle Biosciences (NASDAQ:CSTL) Stock Price - Defense World

May 08, 2025
pulisher
May 07, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initiatives | CSTL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Castle Biosciences Celebrates Skin Cancer Awareness Month - The Manila Times

May 07, 2025
pulisher
May 07, 2025

Castle Biosciences Partners with Melanoma Organizations to Promote Skin Cancer Awareness and Education in May - Nasdaq

May 07, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Rating Maintained as Price Target Lowe - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Rating Maintained as Price Target Lowered | CSTL Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Reports Strong Q1 2025 Revenue Growth - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Target Price Reduced Despite Strong Re - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Target Price Reduced Despite Strong Revenue Report | CSTL Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Castle Biosciences (CSTL) Receives Price Target Adjustment by Ca - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Canaccord Adjusts Price Target for Castle Biosciences (CSTL) | C - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

May 06, 2025

Castle Biosciences Inc (CSTL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research DGX
$173.34
price up icon 0.78%
diagnostics_research WAT
$349.24
price down icon 1.71%
diagnostics_research LH
$248.97
price up icon 0.90%
$157.73
price down icon 0.20%
diagnostics_research MTD
$1,155.52
price down icon 1.51%
diagnostics_research IQV
$140.33
price down icon 0.49%
大文字化:     |  ボリューム (24 時間):